Trials / Conditions / Mitochondrial Disease

Mitochondrial Disease

23 registered clinical trials studyying Mitochondrial Disease — 6 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	Development of a New Technique for Quantifying Mitochondrial DNA in Single Muscle Fibers NCT07511608	Centre Hospitalier Universitaire de Nice	N/A
Not Yet Recruiting	Pilot Study of the Efficacy of Nicotinamide (Vitamin B3) in Leber's Hereditary Optic Neuropathy NCT07258667	University Hospital, Angers	Phase 1
Recruiting	Validation of Nanosensor Oxygen Measurement NCT06819683	Children's Hospital of Philadelphia	Phase 1
Recruiting	Study of N-acetylcysteine in the Treatment of Patients With the m.3243A>G Mutation and Low Brain Glutathione L NCT05241262	Michio Hirano, MD	Phase 1
Completed	Drug-drug Interaction Study of KL1333 in Healthy Subjects NCT04643249	Abliva AB	Phase 1
Recruiting	Acute Infection in Mitochondrial Disease: Metabolism, Infection and Immunity NCT04419870	National Human Genome Research Institute (NHGRI)	—
Completed	Assessment of Small Fiber Neuropathy in Rare Diseases Using Sudoscan NCT02985710	Massachusetts General Hospital	N/A
Completed	GDF-15 as a Biomarker for Mitochondrial Disease NCT02745938	Rigshospitalet, Denmark	—
Completed	Calf Muscle Strength in Mitochondrial Diseases NCT02678637	Rigshospitalet, Denmark	—
Completed	A Dose-escalating Clinical Trial With KH176 NCT02544217	Khondrion BV	Phase 1
Completed	Survey on Supplement Use in Mitochondrial Disease NCT02311257	University of South Florida	—
Completed	Magnetic Resonance Imaging (MRI) Muscle Phenotyping in Mitochondrial Disease NCT02154711	University of Pennsylvania	—
Active Not Recruiting	Mitochondrial Dysfunction in Autism Spectrum Disorder NCT02000284	University of Arkansas	—
Completed	EPI-743 for Metabolism or Mitochondrial Disorders NCT01642056	National Human Genome Research Institute (NHGRI)	Phase 1 / Phase 2
Enrolling By Invitation	Tissue Sample Study for Mitochondrial Disorders NCT01803906	Columbia University	—
Completed	Energy Requirements in Mitochondrial Disease NCT01776918	University of British Columbia	—
Completed	Defining 31Phosphorous Magnetic Resonance Spectroscopy Characteristics in Patients With Mitochondrial Myopathy NCT01301235	Massachusetts General Hospital	—
Completed	Mechanisms of Mitochondrial Defects in Gulf War Syndrome NCT01264471	Medical Neurogenetics, LLC	—
Completed	Economic and Medical Evaluation of the Whole Mitochondrial DNA Screening by Surveyor and Mitochips Techniques NCT00829270	Centre Hospitalier Universitaire de Nice	—
Completed	Mitochondria Inborn Errors of Metabolism and ANT Defects in Mitochondria Diseases NCT00786539	University of California, Irvine	—
Terminated	Anesthetic Effects in Mitochondrial Disease NCT01001585	d sessler	N/A
Available	Expanded Access Program for R007 (Probucol) Tablets in Adults With Mitochondrial Disease and Chronic Kidney Di NCT06931834	RiboNova Inc.	—
No Longer Available	Vatiquinone Expanded Access Protocol NCT07159139	Medical University of South Carolina	—